Biomarker-guided treatment selection in metastatic colorectal cancer: A critical review of established and emerging therapies.

Tojjari A, Pourbahrighesmat S, Alkhazna S, Saeed A

Open source

DOI
10.1016/j.critrevonc.2026.105597
Published
2026 Sep 15
Container
Critical reviews in oncology/hematology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.critrevonc.2026.105597,
  title = {Biomarker-guided treatment selection in metastatic colorectal cancer: A critical review of established and emerging therapies.},
  author = {Tojjari A and Pourbahrighesmat S and Alkhazna S and Saeed A},
  year = {2026},
  journal = {Critical reviews in oncology/hematology},
  doi = {10.1016/j.critrevonc.2026.105597},
  url = {https://doi.org/10.1016/j.critrevonc.2026.105597}
}

RIS

TY  - JOUR
TI  - Biomarker-guided treatment selection in metastatic colorectal cancer: A critical review of established and emerging therapies.
AU  - Tojjari A
AU  - Pourbahrighesmat S
AU  - Alkhazna S
AU  - Saeed A
PY  - 2026
JO  - Critical reviews in oncology/hematology
DO  - 10.1016/j.critrevonc.2026.105597
UR  - https://doi.org/10.1016/j.critrevonc.2026.105597
ER  - 

APA

A, T., S, P., S, A., & A, S. (2026). Biomarker-guided treatment selection in metastatic colorectal cancer: A critical review of established and emerging therapies.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105597

Source records